[S02DA03, antipyrine, The risk or severity of methemoglobinemia can be increased when Isosorbide dinitrate is combined with Antipyrine.]
[B01AD01, streptokinase, The risk or severity of adverse effects can be increased when Streptokinase is combined with Isosorbide dinitrate.]
[L04AA27, fingolimod, The metabolism of Fingolimod can be decreased when combined with Isosorbide dinitrate.]
[J01EC02, sulfadiazine, The risk or severity of methemoglobinemia can be increased when Sulfadiazine is combined with Isosorbide dinitrate.]
[J01EC01, sulfamethoxazole, The risk or severity of methemoglobinemia can be increased when Isosorbide dinitrate is combined with Sulfamethoxazole.]
[J01EB04, sulfapyridine, The risk or severity of methemoglobinemia can be increased when Isosorbide dinitrate is combined with Sulfapyridine.]
[L02BA01, tamoxifen, The metabolism of Tamoxifen can be decreased when combined with Isosorbide dinitrate.]
[S01HA03, tetracaine, The risk or severity of methemoglobinemia can be increased when Isosorbide dinitrate is combined with Tetracaine.]
[N04BC07, apomorphine, The risk or severity of adverse effects can be increased when Apomorphine is combined with Isosorbide dinitrate.]
[L04AX02, thalidomide, The risk or severity of adverse effects can be increased when Isosorbide dinitrate is combined with Thalidomide.]
[R03DA04, theophylline, The metabolism of Theophylline can be decreased when combined with Isosorbide dinitrate.]
[N05CA19, thiopental, Thiopental may increase the hypotensive activities of Isosorbide dinitrate.]
[N05AC02, thioridazine, The risk or severity of adverse effects can be increased when Thioridazine is combined with Isosorbide dinitrate.]
[S01ED01, timolol, The risk or severity of adverse effects can be increased when Timolol is combined with Isosorbide dinitrate.]
[M02AX02, tolazoline, The risk or severity of adverse effects can be increased when Tolazoline is combined with Isosorbide dinitrate.]
[N06AF04, tranylcypromine, Tranylcypromine may increase the orthostatic hypotensive activities of Isosorbide dinitrate.]
[L01XF01, tretinoin, The risk or severity of adverse effects can be increased when Tretinoin is combined with Isosorbide dinitrate.]
[C03DB02, triamterene, The risk or severity of adverse effects can be increased when Triamterene is combined with Isosorbide dinitrate.]
[C03AA06, trichlormethiazide, Isosorbide dinitrate may increase the hypotensive activities of Trichlormethiazide.]
[A03AA05, trimebutine, Trimebutine may increase the vasodilatory activities of Isosorbide dinitrate.]
[N03AC02, trimethadione, Trimethadione may increase the vasodilatory activities of Isosorbide dinitrate.]
[C02BA01, trimethaphan, Isosorbide dinitrate may increase the hypotensive activities of Trimethaphan.]
[C09CA09, azilsartan medoxomil, The risk or severity of adverse effects can be increased when Isosorbide dinitrate is combined with Azilsartan medoxomil.]
[C08DA01, verapamil, Verapamil may increase the vasodilatory activities of Isosorbide dinitrate.]
[C04AX07, vincamine, Isosorbide dinitrate may increase the hypotensive activities of Vincamine.]
[C03BA10, xipamide, Isosorbide dinitrate may increase the hypotensive activities of Xipamide.]
[C07AB03, atenolol, The risk or severity of adverse effects can be increased when Atenolol is combined with Isosorbide dinitrate.]
[G04BE10, avanafil, Avanafil may increase the hypotensive activities of Isosorbide dinitrate.]
[N05CA04, barbital, Barbital may increase the hypotensive activities of Isosorbide dinitrate.]
[N04BD02, rasagiline, Rasagiline may increase the orthostatic hypotensive activities of Isosorbide dinitrate.]
[C08CA13, lercanidipine, Lercanidipine may increase the vasodilatory activities of Isosorbide dinitrate.]
[G04BE03, sildenafil, The risk or severity of hypotension can be increased when Isosorbide dinitrate is combined with Sildenafil.]
[C04AX11, bencyclane, Bencyclane may increase the vasodilatory activities of Isosorbide dinitrate.]
[C03AA01, bendroflumethiazide, The risk or severity of adverse effects can be increased when Bendroflumethiazide is combined with Isosorbide dinitrate.]
[A10BK02, canagliflozin, The risk or severity of adverse effects can be increased when Isosorbide dinitrate is combined with Canagliflozin.]
[R02AD01, benzocaine, The risk or severity of methemoglobinemia can be increased when Isosorbide dinitrate is combined with Benzocaine.]
[M01AH01, celecoxib, The risk or severity of methemoglobinemia can be increased when Celecoxib is combined with Isosorbide dinitrate.]
[P03AX06, benzyl alcohol, The metabolism of Benzyl alcohol can be decreased when combined with Isosorbide dinitrate.]
[C08EA02, bepridil, Bepridil may increase the vasodilatory activities of Isosorbide dinitrate.]
[C02KX05, riociguat, Isosorbide dinitrate may increase the hypotensive activities of Riociguat.]
[C02KX04, macitentan, Isosorbide dinitrate may increase the hypotensive activities of Macitentan.]
[A10BK01, dapagliflozin, The risk or severity of adverse effects can be increased when Isosorbide dinitrate is combined with Dapagliflozin.]
[C07AB04, acebutolol, The risk or severity of adverse effects can be increased when Isosorbide dinitrate is combined with Acebutolol.]
[S01ED02, betaxolol, The risk or severity of adverse effects can be increased when Betaxolol is combined with Isosorbide dinitrate.]
[C02CC01, bethanidine, Isosorbide dinitrate may increase the hypotensive activities of Bethanidine.]
[A10BK03, empagliflozin, The risk or severity of adverse effects can be increased when Isosorbide dinitrate is combined with Empagliflozin.]
[L04AX05, pirfenidone, The metabolism of Pirfenidone can be decreased when combined with Isosorbide dinitrate.]
[N02BE01, acetaminophen, Isosorbide dinitrate may increase the hepatotoxic activities of Acetaminophen.]
[L01CX01, trabectedin, The metabolism of Trabectedin can be decreased when combined with Isosorbide dinitrate.]
[B01AC27, selexipag, Isosorbide dinitrate may increase the hypotensive activities of Selexipag.]
[N04BC01, bromocriptine, The risk or severity of adverse effects can be increased when Isosorbide dinitrate is combined with Bromocriptine.]
[C08CA01, amlodipine, Amlodipine may increase the vasodilatory activities of Isosorbide dinitrate.]
[C03CA02, bumetanide, The risk or severity of adverse effects can be increased when Isosorbide dinitrate is combined with Bumetanide.]
[N01BB01, bupivacaine, The risk or severity of methemoglobinemia can be increased when Bupivacaine is combined with Isosorbide dinitrate.]
[C07AA19, bupranolol, Isosorbide dinitrate may increase the hypotensive activities of Bupranolol.]
[L01XX27, arsenic trioxide, The risk or severity of adverse effects can be increased when Isosorbide dinitrate is combined with Arsenic trioxide.]
[C09AA07, benazepril, The risk or severity of adverse effects can be increased when Benazepril is combined with Isosorbide dinitrate.]
[J01XX08, linezolid, Linezolid may increase the orthostatic hypotensive activities of Isosorbide dinitrate.]
[N04BD03, safinamide, Safinamide may increase the orthostatic hypotensive activities of Isosorbide dinitrate.]
[C07AB07, bisoprolol, The risk or severity of adverse effects can be increased when Bisoprolol is combined with Isosorbide dinitrate.]
[C01DX19, nesiritide, The risk or severity of adverse effects can be increased when Isosorbide dinitrate is combined with Nesiritide.]
[C09AA01, captopril, The risk or severity of adverse effects can be increased when Isosorbide dinitrate is combined with Captopril.]
[C07AG02, carvedilol, Carvedilol may increase the vasodilatory activities of Isosorbide dinitrate.]
[B02BX09, fostamatinib, The risk or severity of hypotension can be increased when Fostamatinib is combined with Isosorbide dinitrate.]
[C07AB08, celiprolol, Isosorbide dinitrate may increase the hypotensive activities of Celiprolol.]
[C09AA08, cilazapril, The risk or severity of adverse effects can be increased when Isosorbide dinitrate is combined with Cilazapril.]
[C09CA06, candesartan, Isosorbide dinitrate may increase the hypotensive activities of Candesartan.]
[C03BX03, cicletanine, Isosorbide dinitrate may increase the hypotensive activities of Cicletanine.]
[C03AA09, cyclothiazide, Isosorbide dinitrate may increase the hypotensive activities of Cyclothiazide.]
[N03AX25, cenobamate, The metabolism of Cenobamate can be decreased when combined with Isosorbide dinitrate.]
[L01EE04, selumetinib, The metabolism of Selumetinib can be decreased when combined with Isosorbide dinitrate.]
[C08CA16, clevidipine, Clevidipine may increase the vasodilatory activities of Isosorbide dinitrate.]
[C02AA06, methoserpidine, Isosorbide dinitrate may increase the hypotensive activities of Methoserpidine.]
[N04BX04, opicapone, The risk or severity of adverse effects can be increased when Isosorbide dinitrate is combined with Opicapone.]
[C08CA17, levamlodipine, Levamlodipine may increase the vasodilatory activities of Isosorbide dinitrate.]
[P01BA01, chloroquine, The risk or severity of methemoglobinemia can be increased when Chloroquine is combined with Isosorbide dinitrate.]
[C03AA04, chlorothiazide, The risk or severity of adverse effects can be increased when Chlorothiazide is combined with Isosorbide dinitrate.]
[N05AA01, chlorpromazine, The risk or severity of adverse effects can be increased when Chlorpromazine is combined with Isosorbide dinitrate.]
[C03BA04, chlorthalidone, The risk or severity of adverse effects can be increased when Chlorthalidone is combined with Isosorbide dinitrate.]
[M03BB03, chlorzoxazone, The metabolism of Chlorzoxazone can be decreased when combined with Isosorbide dinitrate.]
[N06BX18, vinpocetine, Vinpocetine may increase the vasodilatory activities of Isosorbide dinitrate.]
[C01DX22, vericiguat, The risk or severity of adverse effects can be increased when Isosorbide dinitrate is combined with Vericiguat.]
[N03AX10, felbamate, The metabolism of Felbamate can be decreased when combined with Isosorbide dinitrate.]
[C01CA19, fenoldopam, The risk or severity of adverse effects can be increased when Fenoldopam is combined with Isosorbide dinitrate.]
[H04AA02, dasiglucagon, Isosorbide dinitrate may increase the hypotensive activities of Dasiglucagon.]
[N07CA02, cinnarizine, Cinnarizine may increase the vasodilatory activities of Isosorbide dinitrate.]
[N01BB10, levobupivacaine, The risk or severity of adverse effects can be increased when Isosorbide dinitrate is combined with Levobupivacaine.]
[N06AA04, clomipramine, The risk or severity of adverse effects can be increased when Isosorbide dinitrate is combined with Clomipramine.]
[S01EA04, clonidine, The risk or severity of adverse effects can be increased when Clonidine is combined with Isosorbide dinitrate.]
[N05AH02, clozapine, The risk or severity of adverse effects can be increased when Clozapine is combined with Isosorbide dinitrate.]
[C02KB01, metyrosine, Isosorbide dinitrate may increase the hypotensive activities of Metyrosine.]
[N01AB07, desflurane, The risk or severity of adverse effects can be increased when Isosorbide dinitrate is combined with Desflurane.]
[A03AX10, isometheptene, The risk or severity of methemoglobinemia can be increased when Isosorbide dinitrate is combined with Isometheptene.]
[C08CA09, lacidipine, Isosorbide dinitrate may increase the hypotensive activities of Lacidipine.]
[V03AF07, rasburicase, The risk or severity of methemoglobinemia can be increased when Rasburicase is combined with Isosorbide dinitrate.]
[N07BC04, lofexidine, The risk or severity of adverse effects can be increased when Isosorbide dinitrate is combined with Lofexidine.]
[C09AA03, lisinopril, The risk or severity of adverse effects can be increased when Lisinopril is combined with Isosorbide dinitrate.]
[C08CA11, manidipine, Manidipine may increase the vasodilatory activities of Isosorbide dinitrate.]
[C04AX01, cyclandelate, Cyclandelate may increase the vasodilatory activities of Isosorbide dinitrate.]
[C03DA04, eplerenone, The risk or severity of adverse effects can be increased when Eplerenone is combined with Isosorbide dinitrate.]
[C03AA07, cyclopenthiazide, Isosorbide dinitrate may increase the hypotensive activities of Cyclopenthiazide.]
[L01AA01, cyclophosphamide, The risk or severity of methemoglobinemia can be increased when Cyclophosphamide is combined with Isosorbide dinitrate.]
[N06AX07, minaprine, Minaprine may increase the orthostatic hypotensive activities of Isosorbide dinitrate.]
[N06AG02, moclobemide, Moclobemide may increase the orthostatic hypotensive activities of Isosorbide dinitrate.]
[C09AA13, moexipril, The risk or severity of adverse effects can be increased when Moexipril is combined with Isosorbide dinitrate.]
[C03XA02, conivaptan, The risk or severity of adverse effects can be increased when Conivaptan is combined with Isosorbide dinitrate.]
[C02AC05, moxonidine, The risk or severity of adverse effects can be increased when Isosorbide dinitrate is combined with Moxonidine.]
[G04BE09, vardenafil, The risk or severity of hypotension can be increased when Vardenafil is combined with Isosorbide dinitrate.]
[J04BA02, dapsone, The risk or severity of methemoglobinemia can be increased when Dapsone is combined with Isosorbide dinitrate.]
[C02CC04, debrisoquin, Isosorbide dinitrate may increase the hypotensive activities of Debrisoquine.]
[A04AD11, nabilone, The risk or severity of adverse effects can be increased when Nabilone is combined with Isosorbide dinitrate.]
[C07AB12, nebivolol, The risk or severity of adverse effects can be increased when Isosorbide dinitrate is combined with Nebivolol.]
[C01DX16, nicorandil, Nicorandil may increase the hypotensive activities of Isosorbide dinitrate.]
[C09XA02, aliskiren, The risk or severity of adverse effects can be increased when Isosorbide dinitrate is combined with Aliskiren.]
[V03AH01, diazoxide, The risk or severity of adverse effects can be increased when Isosorbide dinitrate is combined with Diazoxide.]
[S01EC02, dichlorphenamide, The risk or severity of adverse effects can be increased when Isosorbide dinitrate is combined with Diclofenamide.]
[C02DG01, pinacidil, Isosorbide dinitrate may increase the hypotensive activities of Pinacidil.]
[A03AX04, pinaverium, Pinaverium may increase the vasodilatory activities of Isosorbide dinitrate.]
[N05AD05, pipamperone, The risk or severity of adverse effects can be increased when Isosorbide dinitrate is combined with Pipamperone.]
[C08CA03, isradipine, Isradipine may increase the vasodilatory activities of Isosorbide dinitrate.]
[C02DB01, dihydralazine, Isosorbide dinitrate may increase the hypotensive activities of Dihydralazine.]
[B01AC21, treprostinil, Isosorbide dinitrate may increase the hypotensive activities of Treprostinil.]
[C08DB01, diltiazem, Diltiazem may increase the vasodilatory activities of Isosorbide dinitrate.]
[C09AA06, quinapril, The risk or severity of adverse effects can be increased when Quinapril is combined with Isosorbide dinitrate.]
[B01AC07, dipyridamole, The risk or severity of hypotension can be increased when Dipyridamole is combined with Isosorbide dinitrate.]
[C09AA05, ramipril, The risk or severity of adverse effects can be increased when Ramipril is combined with Isosorbide dinitrate.]
[N05AX08, risperidone, Isosorbide dinitrate may increase the hypotensive activities of Risperidone.]
[N01BB09, ropivacaine, The risk or severity of methemoglobinemia can be increased when Ropivacaine is combined with Isosorbide dinitrate.]
[G04BE08, tadalafil, The risk or severity of hypotension can be increased when Tadalafil is combined with Isosorbide dinitrate.]
[C02KX02, ambrisentan, Isosorbide dinitrate may increase the hypotensive activities of Ambrisentan.]
[N01AB08, sevoflurane, The metabolism of Sevoflurane can be decreased when combined with Isosorbide dinitrate.]
[C09AA11, spirapril, Isosorbide dinitrate may increase the hypotensive activities of Spirapril.]
[C07AB13, talinolol, Isosorbide dinitrate may increase the hypotensive activities of Talinolol.]
[G04CA03, terazosin, The risk or severity of adverse effects can be increased when Isosorbide dinitrate is combined with Terazosin.]
[G04BD05, terodiline, Terodiline may increase the vasodilatory activities of Isosorbide dinitrate.]
[C09AA02, enalapril, The risk or severity of adverse effects can be increased when Enalapril is combined with Isosorbide dinitrate.]
[N06AG03, toloxatone, Toloxatone may increase the orthostatic hypotensive activities of Isosorbide dinitrate.]
[C03CA04, torsemide, The risk or severity of adverse effects can be increased when Torasemide is combined with Isosorbide dinitrate.]
[C09AA10, trandolapril, The risk or severity of adverse effects can be increased when Trandolapril is combined with Isosorbide dinitrate.]
[N01AB04, enflurane, The metabolism of Enflurane can be decreased when combined with Isosorbide dinitrate.]
[C02CA06, urapidil, Isosorbide dinitrate may increase the hypotensive activities of Urapidil.]
[C08CA12, mepirodipine, Barnidipine may increase the vasodilatory activities of Isosorbide dinitrate.]
[C09AA15, zofenopril, Isosorbide dinitrate may increase the hypotensive activities of Zofenopril.]
[N03AX15, zonisamide, Zonisamide may increase the vasodilatory activities of Isosorbide dinitrate.]
[N05CF01, zopiclone, The risk or severity of methemoglobinemia can be increased when Isosorbide dinitrate is combined with Zopiclone.]
[C02AC02, guanfacine, The risk or severity of adverse effects can be increased when Isosorbide dinitrate is combined with Guanfacine.]
[B01AC11, iloprost, The risk or severity of adverse effects can be increased when Isosorbide dinitrate is combined with Iloprost.]
[N03AG01, valproic acid, The risk or severity of methemoglobinemia can be increased when Valproic acid is combined with Isosorbide dinitrate.]
[V03AF05, amifostine, The risk or severity of adverse effects can be increased when Isosorbide dinitrate is combined with Amifostine.]
[N03AD01, ethosuximide, Ethosuximide may increase the vasodilatory activities of Isosorbide dinitrate.]
[C08CA02, felodipine, Felodipine may increase the vasodilatory activities of Isosorbide dinitrate.]
[C08EA01, fendiline, Fendiline may increase the vasodilatory activities of Isosorbide dinitrate.]
[L01BB06, clofarabine, The risk or severity of adverse effects can be increased when Clofarabine is combined with Isosorbide dinitrate.]
[N07CA03, flunarizine, Flunarizine may increase the vasodilatory activities of Isosorbide dinitrate.]
[V03AZ01, ethanol, Ethanol may increase the hypotensive and vasodilatory activities of Isosorbide dinitrate.]
[N05AG01, fluspirilene, Fluspirilene may increase the vasodilatory activities of Isosorbide dinitrate.]
[L02BB01, flutamide, The risk or severity of methemoglobinemia can be increased when Flutamide is combined with Isosorbide dinitrate.]
[G01AX06, furazolidone, Furazolidone may increase the orthostatic hypotensive activities of Isosorbide dinitrate.]
[C03CA01, furosemide, The risk or severity of adverse effects can be increased when Furosemide is combined with Isosorbide dinitrate.]
[C08DA02, gallopamil, Gallopamil may increase the vasodilatory activities of Isosorbide dinitrate.]
[N03AA04, barbexaclone, Barbexaclone may increase the hypotensive activities of Isosorbide dinitrate.]
[N03AD03, methsuximide, Methsuximide may increase the vasodilatory activities of Isosorbide dinitrate.]
[N05CM18, dexmedetomidine, The risk or severity of adverse effects can be increased when Dexmedetomidine is combined with Isosorbide dinitrate.]
[C05AE01, nitroglycerin, The risk or severity of methemoglobinemia can be increased when Nitroglycerin is combined with Isosorbide dinitrate.]
[C02CA04, doxazosin, The risk or severity of adverse effects can be increased when Doxazosin is combined with Isosorbide dinitrate.]
[C07AB09, esmolol, The risk or severity of adverse effects can be increased when Esmolol is combined with Isosorbide dinitrate.]
[C09AA09, fosinopril, The risk or severity of adverse effects can be increased when Fosinopril is combined with Isosorbide dinitrate.]
[S01EX01, guanethidine, Isosorbide dinitrate may increase the hypotensive activities of Guanethidine.]
[N01AB01, halothane, The metabolism of Halothane can be decreased when combined with Isosorbide dinitrate.]
[N05AH04, quetiapine, The risk or severity of adverse effects can be increased when Isosorbide dinitrate is combined with Quetiapine.]
[C09CA01, losartan, The risk or severity of adverse effects can be increased when Losartan is combined with Isosorbide dinitrate.]
[N05CA16, hexobarbital, Hexobarbital may increase the hypotensive activities of Isosorbide dinitrate.]
[C08CA10, nilvadipine, Nilvadipine may increase the vasodilatory activities of Isosorbide dinitrate.]
[M02AA26, nimesulide, Nimesulide may increase the vasodilatory activities of Isosorbide dinitrate.]
[C09AA04, perindopril, The risk or severity of adverse effects can be increased when Perindopril is combined with Isosorbide dinitrate.]
[C03AA03, hydrochlorothiazide, The risk or severity of adverse effects can be increased when Isosorbide dinitrate is combined with Hydrochlorothiazide.]
[C03AA02, hydroflumethiazide, The risk or severity of adverse effects can be increased when Hydroflumethiazide is combined with Isosorbide dinitrate.]
[L01XX05, hydroxyurea, The risk or severity of methemoglobinemia can be increased when Isosorbide dinitrate is combined with Hydroxyurea.]
[C02AC06, rilmenidine, Isosorbide dinitrate may increase the hypotensive activities of Rilmenidine.]
[L01AA06, ifosfamide, The risk or severity of methemoglobinemia can be increased when Isosorbide dinitrate is combined with Ifosfamide.]
[N01AH03, sufentanil, The risk or severity of adverse effects can be increased when Sufentanil is combined with Isosorbide dinitrate.]
[N06AA02, imipramine, The risk or severity of adverse effects can be increased when Imipramine is combined with Isosorbide dinitrate.]
[L01CD01, paclitaxel, The risk or severity of adverse effects can be increased when Isosorbide dinitrate is combined with Paclitaxel.]
[M03BX02, tizanidine, The risk or severity of adverse effects can be increased when Tizanidine is combined with Isosorbide dinitrate.]
[C03BA11, indapamide, The risk or severity of adverse effects can be increased when Indapamide is combined with Isosorbide dinitrate.]
[C02CA02, indoramin, The risk or severity of adverse effects can be increased when Isosorbide dinitrate is combined with Indoramin.]
[N01BB08, articaine, The risk or severity of methemoglobinemia can be increased when Isosorbide dinitrate is combined with Articaine.]
[C07AA01, alprenolol, Isosorbide dinitrate may increase the hypotensive activities of Alprenolol.]
[N06AF05, iproniazid, Iproniazid may increase the orthostatic hypotensive activities of Isosorbide dinitrate.]
[N06AF01, isocarboxazid, Isocarboxazid may increase the orthostatic hypotensive activities of Isosorbide dinitrate.]
[C09AA16, imidapril, The risk or severity of adverse effects can be increased when Isosorbide dinitrate is combined with Imidapril.]
[N01AB06, isoflurane, The metabolism of Isoflurane can be decreased when combined with Isosorbide dinitrate.]
[C01DA14, isosorbide mononitrate, Isosorbide dinitrate may increase the vasodilatory activities of Isosorbide mononitrate.]
[C04AA01, isoxsuprine, The risk or severity of adverse effects can be increased when Isosorbide dinitrate is combined with Isoxsuprine.]
[C02KD01, ketanserin, Isosorbide dinitrate may increase the hypotensive activities of Ketanserin.]
[N05AH03, olanzapine, The risk or severity of adverse effects can be increased when Olanzapine is combined with Isosorbide dinitrate.]
[N04BC09, rotigotine, The risk or severity of adverse effects can be increased when Isosorbide dinitrate is combined with Rotigotine.]
[C07AG01, labetalol, The risk or severity of adverse effects can be increased when Labetalol is combined with Isosorbide dinitrate.]
[C02AA05, deserpidine, Isosorbide dinitrate may increase the hypotensive activities of Deserpidine.]
[N04BA01, levodopa, The risk or severity of hypotension and orthostatic hypotension can be increased when Isosorbide dinitrate is combined with Levodopa.]
[S02DA01, lidocaine, The risk or severity of methemoglobinemia can be increased when Lidocaine is combined with Isosorbide dinitrate.]
[C08EX01, lidoflazine, Lidoflazine may increase the vasodilatory activities of Isosorbide dinitrate.]
[C03DB01, amiloride, The risk or severity of adverse effects can be increased when Amiloride is combined with Isosorbide dinitrate.]
[A07DA03, loperamide, Loperamide may increase the vasodilatory activities of Isosorbide dinitrate.]
[V04CC02, magnesium sulfate, Magnesium sulfate may increase the vasodilatory activities of Isosorbide dinitrate.]
[V04CX04, mannitol, The risk or severity of adverse effects can be increased when Mannitol is combined with Isosorbide dinitrate.]
[C02BB01, mecamylamine, The risk or severity of adverse effects can be increased when Mecamylamine is combined with Isosorbide dinitrate.]
[N03AA01, mephobarbital, Methylphenobarbital may increase the hypotensive activities of Isosorbide dinitrate.]
[N01BB03, mepivacaine, The risk or severity of methemoglobinemia can be increased when Isosorbide dinitrate is combined with Mepivacaine.]
[S01EC05, methazolamide, The risk or severity of adverse effects can be increased when Methazolamide is combined with Isosorbide dinitrate.]
[N05CA15, methohexital, Methohexital may increase the hypotensive activities of Isosorbide dinitrate.]
[N02BG09, methoxyflurane, The metabolism of Methoxyflurane can be decreased when combined with Isosorbide dinitrate.]
[C03AA08, methyclothiazide, The risk or severity of adverse effects can be increased when Methyclothiazide is combined with Isosorbide dinitrate.]
[C02AB01, methyldopa, The risk or severity of adverse effects can be increased when Isosorbide dinitrate is combined with Methyldopa.]
[V04CG05, methylene blue, Methylene blue may increase the orthostatic hypotensive activities of Isosorbide dinitrate.]
[R03DA05, aminophylline, The metabolism of Aminophylline can be decreased when combined with Isosorbide dinitrate.]
[A03FA01, metoclopramide, The risk or severity of methemoglobinemia can be increased when Isosorbide dinitrate is combined with Metoclopramide.]
[C03BA08, metolazone, The risk or severity of adverse effects can be increased when Metolazone is combined with Isosorbide dinitrate.]
[C07AB02, metoprolol, The risk or severity of adverse effects can be increased when Metoprolol is combined with Isosorbide dinitrate.]
[C09CA03, valsartan, The risk or severity of adverse effects can be increased when Valsartan is combined with Isosorbide dinitrate.]
[D11AX01, minoxidil, The risk or severity of adverse effects can be increased when Minoxidil is combined with Isosorbide dinitrate.]
[L03AC01, aldesleukin, The risk or severity of adverse effects can be increased when Aldesleukin is combined with Isosorbide dinitrate.]
[C01DX12, molsidomine, Molsidomine may increase the hypotensive activities of Isosorbide dinitrate.]
[C01BD01, amiodarone, Amiodarone may increase the vasodilatory activities of Isosorbide dinitrate.]
[N02AA01, morphine, The risk or severity of adverse effects can be increased when Morphine is combined with Isosorbide dinitrate.]
[N05CA02, amobarbital, Amobarbital may increase the hypotensive activities of Isosorbide dinitrate.]
[C07AA12, nadolol, The risk or severity of adverse effects can be increased when Isosorbide dinitrate is combined with Nadolol.]
[N04BC04, ropinirole, The risk or severity of adverse effects can be increased when Ropinirole is combined with Isosorbide dinitrate.]
[N06AX21, duloxetine, The risk or severity of orthostatic hypotension and syncope can be increased when Isosorbide dinitrate is combined with Duloxetine.]
[N04BX01, tolcapone, The risk or severity of adverse effects can be increased when Tolcapone is combined with Isosorbide dinitrate.]
[N01AH06, remifentanil, The risk or severity of adverse effects can be increased when Isosorbide dinitrate is combined with Remifentanil.]
[C01CX08, levosimendan, The risk or severity of adverse effects can be increased when Isosorbide dinitrate is combined with Levosimendan.]
[J02AA01, amphotericin B, The risk or severity of adverse effects can be increased when Amphotericin B is combined with Isosorbide dinitrate.]
[C09CA07, telmisartan, The risk or severity of adverse effects can be increased when Isosorbide dinitrate is combined with Telmisartan.]
[N06AF02, nialamide, Nialamide may increase the orthostatic hypotensive activities of Isosorbide dinitrate.]
[C08CA04, nicardipine, Nicardipine may increase the vasodilatory activities of Isosorbide dinitrate.]
[C08CA05, nifedipine, Nifedipine may increase the vasodilatory activities of Isosorbide dinitrate.]
[V03AB22, amyl nitrite, The risk or severity of methemoglobinemia can be increased when Isosorbide dinitrate is combined with Amyl Nitrite.]
[C08CA06, nimodipine, Nimodipine may increase the vasodilatory activities of Isosorbide dinitrate.]
[C08CA07, nisoldipine, Nisoldipine may increase the vasodilatory activities of Isosorbide dinitrate.]
[C08CA08, nitrendipine, Nitrendipine may increase the vasodilatory activities of Isosorbide dinitrate.]
[R07AX01, nitric oxide, The risk or severity of methemoglobinemia can be increased when Nitric Oxide is combined with Isosorbide dinitrate.]
[J01XE01, nitrofurantoin, The risk or severity of methemoglobinemia can be increased when Nitrofurantoin is combined with Isosorbide dinitrate.]
[N04BC05, pramipexole, The risk or severity of adverse effects can be increased when Pramipexole is combined with Isosorbide dinitrate.]
[C02DD01, nitroprusside, The risk or severity of methemoglobinemia can be increased when Nitroprusside is combined with Isosorbide dinitrate.]
[N01AX13, nitrous oxide, The risk or severity of methemoglobinemia can be increased when Isosorbide dinitrate is combined with Nitrous oxide.]
[C02KX01, bosentan, Isosorbide dinitrate may increase the hypotensive activities of Bosentan.]
[G02CA02, nylidrin, Nylidrin may increase the vasodilatory activities of Isosorbide dinitrate.]
[G04CA02, tamsulosin, The risk or severity of adverse effects can be increased when Tamsulosin is combined with Isosorbide dinitrate.]
[C07AA02, oxprenolol, The risk or severity of adverse effects can be increased when Isosorbide dinitrate is combined with Oxprenolol.]
[J04AA01, aminosalicylic acid, The risk or severity of methemoglobinemia can be increased when Aminosalicylic acid is combined with Isosorbide dinitrate.]
[G04BE02, papaverine, The risk or severity of adverse effects can be increased when Isosorbide dinitrate is combined with Papaverine.]
[C02KC01, pargyline, Pargyline may increase the orthostatic hypotensive activities of Isosorbide dinitrate.]
[C07AA23, penbutolol, The risk or severity of adverse effects can be increased when Isosorbide dinitrate is combined with Penbutolol.]
[N05AG03, penfluridol, Penfluridol may increase the vasodilatory activities of Isosorbide dinitrate.]
[N05CA01, pentobarbital, Pentobarbital may increase the hypotensive activities of Isosorbide dinitrate.]
[C08EX02, perhexiline, Perhexiline may increase the vasodilatory activities of Isosorbide dinitrate.]
[G04BX06, phenazopyridine, The risk or severity of methemoglobinemia can be increased when Isosorbide dinitrate is combined with Phenazopyridine.]
[N06AF03, phenelzine, Phenelzine may increase the orthostatic hypotensive activities of Isosorbide dinitrate.]
[N03AA02, phenobarbital, The metabolism of Phenobarbital can be decreased when combined with Isosorbide dinitrate.]
[C04AX02, phenoxybenzamine, The risk or severity of adverse effects can be increased when Isosorbide dinitrate is combined with Phenoxybenzamine.]
[V03AB36, phentolamine, The risk or severity of adverse effects can be increased when Phentolamine is combined with Isosorbide dinitrate.]
[N03AB02, phenytoin, The risk or severity of methemoglobinemia can be increased when Phenytoin is combined with Isosorbide dinitrate.]
[C08CX01, mibefradil, Mibefradil may increase the vasodilatory activities of Isosorbide dinitrate.]
[C07AA03, pindolol, The risk or severity of adverse effects can be increased when Isosorbide dinitrate is combined with Pindolol.]
[C09CA02, eprosartan, The risk or severity of adverse effects can be increased when Eprosartan is combined with Isosorbide dinitrate.]
[C09CA04, irbesartan, The risk or severity of adverse effects can be increased when Isosorbide dinitrate is combined with Irbesartan.]
[A10BG02, rosiglitazone, The risk or severity of adverse effects can be increased when Isosorbide dinitrate is combined with Rosiglitazone.]
[C03AA05, polythiazide, Isosorbide dinitrate may increase the hypotensive activities of Polythiazide.]
[C07AB01, practolol, Isosorbide dinitrate may increase the hypotensive activities of Practolol.]
[C02CA01, prazosin, The risk or severity of adverse effects can be increased when Prazosin is combined with Isosorbide dinitrate.]
[C01DX02, prenylamine, Prenylamine may increase the vasodilatory activities of Isosorbide dinitrate.]
[N01BB04, prilocaine, The risk or severity of methemoglobinemia can be increased when Isosorbide dinitrate is combined with Prilocaine.]
[P01BA03, primaquine, The risk or severity of methemoglobinemia can be increased when Isosorbide dinitrate is combined with Primaquine.]
[N03AA03, primidone, Primidone may increase the hypotensive activities of Isosorbide dinitrate.]
[S01HA05, procaine, Procaine may increase the orthostatic hypotensive activities of Isosorbide dinitrate.]
[L01XB01, procarbazine, Procarbazine may increase the orthostatic hypotensive activities of Isosorbide dinitrate.]
[N01AX10, propofol, The risk or severity of adverse effects can be increased when Propofol is combined with Isosorbide dinitrate.]
[C07AA05, propranolol, The risk or severity of adverse effects can be increased when Propranolol is combined with Isosorbide dinitrate.]
[B01AC09, epoprostenol, The risk or severity of adverse effects can be increased when Isosorbide dinitrate is combined with Epoprostenol.]
[N05AX12, aripiprazole, Aripiprazole may increase the hypotensive activities of Isosorbide dinitrate.]
[P01BC01, quinine, The risk or severity of methemoglobinemia can be increased when Quinine is combined with Isosorbide dinitrate.]
[C02AA01, rescinnamine, Isosorbide dinitrate may increase the hypotensive activities of Rescinnamine.]
[C02AA02, reserpine, The risk or severity of adverse effects can be increased when Reserpine is combined with Isosorbide dinitrate.]
[A07EC01, sulfasalazine, The risk or severity of methemoglobinemia can be increased when Sulfasalazine is combined with Isosorbide dinitrate.]
[N05CA06, secobarbital, Secobarbital may increase the hypotensive activities of Isosorbide dinitrate.]
[N04BD01, selegiline, Selegiline may increase the orthostatic hypotensive activities of Isosorbide dinitrate.]
[L01FA03, obinutuzumab, The risk or severity of adverse effects can be increased when Isosorbide dinitrate is combined with Obinutuzumab.]
[C07AA07, sotalol, The risk or severity of adverse effects can be increased when Sotalol is combined with Isosorbide dinitrate.]
[C03DA01, spironolactone, The risk or severity of adverse effects can be increased when Spironolactone is combined with Isosorbide dinitrate.]
[C03CC01, ethacrynic acid, The risk or severity of adverse effects can be increased when Isosorbide dinitrate is combined with Etacrynic acid.]
